Machine learning prognosis model based on patient-reported outcomes for chronic heart failure patients after discharge
Source check: Source checked. Not independent scientific confirmation.
Finding: Prospective CHF-PRO models predict two-year outcomes and compare six algorithms with validation data; discrimination is modest for some endpoints and should not be represented as strong clinical decision accuracy.
Technology: Six machine-learning algorithms model two-year heart-failure outcomes; XGBoost provides the reported predictions.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Six machine-learning algorithms model two-year heart-failure outcomes; XGBoost provides the reported predictions.
- Test and result
- 941 prospective-cohort patients, 2-year mortality/HF hospitalization/MACE; six ML approaches, 10-fold tuning, separate Shanxi Cardiovascular Hospital validation; XGBoost AUC .754/.718/.670.
- Limitation / still unknown
- Methods/Results: 941 prospective-cohort patients, 2-year mortality/HF hospitalization/MACE; six ML approaches, 10-fold tuning, separate Shanxi Cardiovascular Hospital validation; XGBoost AUC .754/.718/.670.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12955-023-02109-x · https://pubmed.ncbi.nlm.nih.gov/36978124/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.